These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection. Hung CY; Hurtgen BJ; Bellecourt M; Sanderson SD; Morgan EL; Cole GT Vaccine; 2012 Jun; 30(31):4681-90. PubMed ID: 22575167 [TBL] [Abstract][Full Text] [Related]
13. Protection against lethal murine coccidioidomycosis by a soluble vaccine from spherules. Zimmermann CR; Johnson SM; Martens GW; White AG; Zimmer BL; Pappagianis D Infect Immun; 1998 May; 66(5):2342-5. PubMed ID: 9573127 [TBL] [Abstract][Full Text] [Related]
14. Molecular and cellular mechanisms of protective immunity to coccidioidomycosis. Kirkland TN; Raz E; Datta SK Vaccine; 2006 Jan; 24(4):495-500. PubMed ID: 16181709 [TBL] [Abstract][Full Text] [Related]
15. A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis. Xue J; Chen X; Selby D; Hung CY; Yu JJ; Cole GT Infect Immun; 2009 Aug; 77(8):3196-208. PubMed ID: 19487479 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group. Pappagianis D Am Rev Respir Dis; 1993 Sep; 148(3):656-60. PubMed ID: 8368636 [TBL] [Abstract][Full Text] [Related]